Welcome to a journey of optimizing your health by naturally increasing GLP-1 levels
The best option for you will depend on which medication offers the greatest benefits with the least risk, based on your individual health needs
Semaglutide, with its 7-day half-life and once-weekly dosing, represents the longest-acting formulation currently available [23]
Aim for at least 150 minutes of moderate-intensity exercise, like brisk walking, each week
Current and Pipeline GLP-1 Agonists Following the 2005 approval of exenatide for Type 2 Diabetes, there have been a series of approvals for GLP-1 agonists in both diabetes and obesity
We have eagerly awaited seeing the actual results since the sponsor company (Novo Nordisk) issued a press release in August that proclaimed a 20% relative reduction of cardiovascular death, heart attack or stroke, the primary endpoint of the trial